Lixisenatide studies: 116 papers with results
Page 3 of 3
Lixisenatide has 428 linked papers. PepBank read up to 120 of the most-cited studies that gave it to people, up to 20 other studies, and the main trials.
- Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease.
McClean PL · Neuropharmacology · 2014
Animal study (in vivo) · mouse · 16 results
- The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype.
Vinué Á · Diabetologia · 2017
Animal study (in vivo) · mouse · 18 results
- The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice.
Baggio LL · Molecular metabolism · 2017
Animal study (in vivo) · mouse · 8 results
- Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
Cai HY · Neuroscience · 2014
Animal study (in vivo) · rat · 5 results
- Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease.
Cai HY · Biochemical and biophysical research communications · 2018
Animal study (in vivo) · mouse · 3 results
- Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies.
Wohlfart P · Journal of translational medicine · 2013
Animal study (in vivo) · rat · 10 results
- Signalling, trafficking and glucoregulatory properties of glucagon-like peptide-1 receptor agonists exendin-4 and lixisenatide.
Pickford P · British journal of pharmacology · 2020
Animal study (in vivo) · mouse · 8 results
- Lixisenatide improves recognition memory and exerts neuroprotective actions in high-fat fed mice.
Lennox R · Peptides · 2014
Animal study (in vivo) · mouse · 10 results
- Lixisenatide attenuates the detrimental effects of amyloid β protein on spatial working memory and hippocampal neurons in rats.
Cai HY · Behavioural brain research · 2017
Animal study (in vivo) · rat · 5 results
- Empagliflozin Contributes to Polyuria via Regulation of Sodium Transporters and Water Channels in Diabetic Rat Kidneys.
Chung S · Frontiers in physiology · 2019
Animal study (in vivo) · rat · 1 result
- Lixisenatide, a novel GLP-1 analog, protects against cerebral ischemia/reperfusion injury in diabetic rats.
Abdel-Latif RG · Naunyn-Schmiedeberg's archives of pharmacology · 2018
Animal study (in vivo) · rat · 8 results
- Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats.
Yu J · Surgery today · 2016
Animal study (in vivo) · rat · 6 results
- The protective effects of lixisenatide against inflammatory response in human rheumatoid arthritis fibroblast-like synoviocytes.
Du X · International immunopharmacology · 2019
In vitro (cells) · 4 results
- Effect of anti-hyperglycemic drugs on endoplasmic reticulum (ER) stress in human coronary artery endothelial cells.
Kapadia P · European journal of pharmacology · 2021
In vitro (cells) · 12 results
- Lixisenatide enhances mitochondrial biogenesis and function through regulating the CREB/PGC-1α pathway.
Zhao Z · Biochemical and biophysical research communications · 2019
In vitro (cells) · 9 results
- Sustained Release Strategy Designed for Lixisenatide Delivery to Synchronously Treat Diabetes and Associated Complications.
Zhuang Y · ACS applied materials & interfaces · 2019
Not a test of Lixisenatide alone · 11 results